Search in:

Diabetes, Metabolic Syndrome and Obesity Volume 12, 2019 - Issue

Submit an article Journal homepage

Open access

679

Views

CrossRef citations to date

Altmetric

Review

Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date

Sam Pearson1 Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, West Yorkshire LS2 9JT, UK

https://orcid.org/0000-0002-4943-6759

Noppadol Kietsiriroje1 Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, West Yorkshire LS2 9JT, UK;2 Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hatyai, Songkhla 90110, Thailand

https://orcid.org/0000-0002-5076-4450

Ramzi A Ajjan1 Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, West Yorkshire LS2 9JT, UKCorrespondence[email protected]

Pages 2515-2529 | Published online: 02 Dec 2019

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (16)

Xiang Zhang, Suki Ha, Harry Cheuk-Hay Lau & Jun Yu. (2023) Excess body weight: Novel insights into its roles in obesity comorbidities. Seminars in Cancer Biology 92, pages 16-27.
Crossref

Kalpna Jakhar, Swetha Vaishnavi, Prabhsimran Kaur, Paramdeep Singh & Anjana Munshi. (2022) Pharmacogenomics of GLP-1 receptor agonists: Focus on pharmacological profile. European Journal of Pharmacology 936, pages 175356.
Crossref

John T. O’Brien, Leonidas Chouliaras, Janet Sultana, John-Paul Taylor, Clive Ballard, Dag Aarsland, Frederic Blanc, Bradley Boeve, David J. Brooks, K. Ray Chaudhuri, Jeffrey Cummings, Howard H. Feldman, Leon Flicker, James E. Galvin, Donald G. Grosset, Manabu Ikeda, Susan Kohlhaas, Brian Lawlor, Afina W. Lemstra, Iracema Leroi, Elisabet Londos, James B. Leverenz, Simon Lewis, Ian McKeith, Roger Mills, Richard Oakley, Jill Richardson, Marwan Sabbagh, John Skidmore, Per Svennigsson, Pietro Tiraboschi, Daniel Weintraub, Zuzana Walker, Rosie Watson, Rimona S. Weil, Caroline H. Williams-Gray & Alison Yarnall. (2022) RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia—an international Delphi consensus. Alzheimer's Research & Therapy 14:1.
Crossref

Jay H. Shubrook, Michael Radin, Sarah N. Ali, Barrie Chubb, Kristina DiPietrantonio, Hannah Collings, Robin Wyn & Martina Smith. (2022) Preference for Type 2 Diabetes Therapies in the United States: A Discrete Choice Experiment. Advances in Therapy 39:9, pages 4114-4130.
Crossref

Ilora Bandyopadhyay, Sunny Dave, Amita Rai, Madhavan Nampoothiri, Mallikarjuna Rao Chamallamudi & Nitesh Kumar. (2022) Oral Semaglutide in the Management of Type 2 DM: Clinical Status and Comparative Analysis. Current Drug Targets 23:3, pages 311-327.
Crossref

Sumin Kang, Nam Hyuk Kim & Yeon Gyu Yu. (2021) Identification of novel positive allosteric modulators of GLP1R that stimulate its interaction with ligands and Gα subunits. Biochemical and Biophysical Research Communications 583, pages 162-168.
Crossref

Yuxue Cao, Prarthana Rewatkar, Ran Wang, Sumaira Z. Hasnain, Amirali Popat & Tushar Kumeria. (2021) Nanocarriers for oral delivery of biologics: small carriers for big payloads. Trends in Pharmacological Sciences 42:11, pages 957-972.
Crossref

Donna H. Ryan. (2021) Next Generation Antiobesity Medications: Setmelanotide, Semaglutide, Tirzepatide and Bimagrumab: What do They Mean for Clinical Practice?. Journal of Obesity & Metabolic Syndrome 30:3, pages 196-208.
Crossref

David Morris. (2021) Improving outcomes for older people with diabetes. Practice Nursing 32:7, pages 270-276.
Crossref

Prateek Sharma, Sukhbir Singh, Vinay Thakur, Neelam Sharma & Ajmer Singh Grewal. (2021) Novel and emerging therapeutic drug targets for management of type 2 Diabetes Mellitus. Obesity Medicine 23, pages 100329.
Crossref

Md Kamruzzaman, Michael Horowitz, Karen L. Jones & Chinmay S. Marathe. (2021) Gut-Based Strategies to Reduce Postprandial Glycaemia in Type 2 Diabetes. Frontiers in Endocrinology 12.
Crossref

Noura G. Eissa, Mahmoud Elsabahy & Ayat Allam. (2021) Engineering of smart nanoconstructs for delivery of glucagon-like peptide-1 analogs. International Journal of Pharmaceutics 597, pages 120317.
Crossref

Donna H. Ryan. 2022. From Obesity to Diabetes. From Obesity to Diabetes 387 414 .

Cheng Peng, Alastair G. Stewart, Owen L. Woodman, Rebecca H. Ritchie & Cheng Xue Qin. (2020) Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments. Frontiers in Pharmacology 11.
Crossref

Xin Zhang, Matthew J. Belousoff, Peishen Zhao, Albert J. Kooistra, Tin T. Truong, Sheng Yu Ang, Christina Rye Underwood, Thomas Egebjerg, Petr Šenel, Gregory D. Stewart, Yi-Lynn Liang, Alisa Glukhova, Hari Venugopal, Arthur Christopoulos, Sebastian G.B. Furness, Laurence J. Miller, Steffen Reedtz-Runge, Christopher J. Langmead, David E. Gloriam, Radostin Danev, Patrick M. Sexton & Denise Wootten. (2020) Differential GLP-1R Binding and Activation by Peptide and Non-peptide Agonists. Molecular Cell 80:3, pages 485-500.e7.
Crossref

Goutham Rao & Elizabeth T. Jensen. (2021) Type 2 Diabetes in Youth. Global Pediatric Health 7, pages 2333794X2098134.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date

Articles from other publishers (16)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date

Citations (16)

Articles from other publishers (16)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date